Massachusetts Financial Services Co. MA Sells 164,861 Shares of Sally Beauty Holdings, Inc. (NYSE:SBH)

Share on StockTwits

Massachusetts Financial Services Co. MA lowered its stake in Sally Beauty Holdings, Inc. (NYSE:SBH) by 2.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,872,086 shares of the specialty retailer’s stock after selling 164,861 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 4.87% of Sally Beauty worth $87,435,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Sally Beauty by 17.9% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 4,176 shares of the specialty retailer’s stock worth $62,000 after acquiring an additional 634 shares during the last quarter. Advisory Services Network LLC increased its stake in shares of Sally Beauty by 42.3% in the second quarter. Advisory Services Network LLC now owns 2,396 shares of the specialty retailer’s stock valued at $32,000 after buying an additional 712 shares during the period. Arizona State Retirement System increased its stake in shares of Sally Beauty by 1.1% in the second quarter. Arizona State Retirement System now owns 87,515 shares of the specialty retailer’s stock valued at $1,167,000 after buying an additional 952 shares during the period. Oregon Public Employees Retirement Fund increased its stake in shares of Sally Beauty by 2.1% in the second quarter. Oregon Public Employees Retirement Fund now owns 48,756 shares of the specialty retailer’s stock valued at $650,000 after buying an additional 989 shares during the period. Finally, Empirical Finance LLC increased its stake in shares of Sally Beauty by 0.9% in the second quarter. Empirical Finance LLC now owns 125,851 shares of the specialty retailer’s stock valued at $1,679,000 after buying an additional 1,085 shares during the period.

Several research analysts have recently issued reports on the company. DA Davidson downgraded Sally Beauty from a “neutral” rating to an “underperform” rating and upped their price objective for the company from $12.50 to $15.00 in a research note on Thursday. ValuEngine downgraded Sally Beauty from a “sell” rating to a “strong sell” rating in a research note on Friday, November 8th. Four research analysts have rated the stock with a sell rating and four have given a hold rating to the company. Sally Beauty currently has a consensus rating of “Hold” and an average target price of $15.83.

Shares of Sally Beauty stock traded up $0.07 on Friday, hitting $19.08. The stock had a trading volume of 109,990 shares, compared to its average volume of 1,926,843. The stock has a 50 day moving average of $16.20 and a 200 day moving average of $14.57. Sally Beauty Holdings, Inc. has a twelve month low of $11.46 and a twelve month high of $21.98. The firm has a market capitalization of $2.40 billion, a P/E ratio of 8.45, a PEG ratio of 2.29 and a beta of 0.46.

Sally Beauty (NYSE:SBH) last released its quarterly earnings data on Thursday, November 7th. The specialty retailer reported $0.58 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.05. Sally Beauty had a negative return on equity of 189.31% and a net margin of 7.01%. The company had revenue of $965.94 million during the quarter, compared to the consensus estimate of $955.06 million. During the same quarter in the prior year, the firm posted $0.51 earnings per share. The firm’s revenue was up .0% compared to the same quarter last year. On average, equities analysts anticipate that Sally Beauty Holdings, Inc. will post 2.31 earnings per share for the current year.

In other news, Director John A. Miller bought 40,500 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was acquired at an average price of $12.21 per share, with a total value of $494,505.00. Following the transaction, the director now owns 51,873 shares of the company’s stock, valued at approximately $633,369.33. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Marshall E. Eisenberg bought 10,000 shares of the firm’s stock in a transaction on Tuesday, August 20th. The shares were purchased at an average cost of $11.89 per share, with a total value of $118,900.00. Following the transaction, the director now directly owns 72,071 shares in the company, valued at approximately $856,924.19. The disclosure for this purchase can be found here. Insiders have acquired a total of 51,500 shares of company stock valued at $625,675 in the last three months. Insiders own 1.04% of the company’s stock.

About Sally Beauty

Sally Beauty Holdings, Inc operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply segment offers beauty products, including hair color and care, skin and nail care, styling tools, and other beauty products for retail customers and salon professionals.

Recommended Story: Commodities

Want to see what other hedge funds are holding SBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sally Beauty Holdings, Inc. (NYSE:SBH).

Institutional Ownership by Quarter for Sally Beauty (NYSE:SBH)

Receive News & Ratings for Sally Beauty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sally Beauty and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Tristate Capital Holdings Inc  Given Average Rating of “Buy” by Analysts
Tristate Capital Holdings Inc Given Average Rating of “Buy” by Analysts
HARGREAVES LANS/ADR  Downgraded by Zacks Investment Research
HARGREAVES LANS/ADR Downgraded by Zacks Investment Research
ConvaTec Group  Given “Buy” Rating at Peel Hunt
ConvaTec Group Given “Buy” Rating at Peel Hunt
Crest Nicholson  Price Target Raised to GBX 412 at Liberum Capital
Crest Nicholson Price Target Raised to GBX 412 at Liberum Capital
Silence Therapeutics  Earns “Buy” Rating from Peel Hunt
Silence Therapeutics Earns “Buy” Rating from Peel Hunt
Rightmove  Upgraded to “Neutral” by Goldman Sachs Group
Rightmove Upgraded to “Neutral” by Goldman Sachs Group


© 2006-2019 Ticker Report